Media Stories Biocon Global Biopharmaceutical Company Access our news section press releases, company statements, media stories, factsheet, leadership profile, reports, video & image gallery. Biocon biologics secures full global rights to biosimilar adalimumab through expanded fkb in licensing agreement tue, 23 dec 2025 posted by: biocon biologics no comments.
Press Releases Biocon Global Biopharmaceutical Company You are now leaving the biocon biologics corporate website for a biocon biologics eu corporate microsite that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Yesintek and jobevne are trademarks of biocon biologics limited. fulphila, ogivri, semglee, kirsty, the adalimumab fkjp, biocon biologics and the biocon biologics logo are registered trademarks of biocon biologics limited. Biocon limited (bse code: 532523, nse: biocon), an innovation led global biopharmaceutical company, today announced the inauguration of its first u.s . Biocon limited (bse code: 532523, nse: biocon), an innovation led global biopharmaceuticals company, today announced its consolidated financial results for the fiscal second quarter ended september 30, 2025.
Press Releases Biocon Global Biopharmaceutical Company Biocon limited (bse code: 532523, nse: biocon), an innovation led global biopharmaceutical company, today announced the inauguration of its first u.s . Biocon limited (bse code: 532523, nse: biocon), an innovation led global biopharmaceuticals company, today announced its consolidated financial results for the fiscal second quarter ended september 30, 2025. "we are incredibly grateful that biocon has decided to open its first u.s. manufacturing facility in the garden state," said governor murphy. "for years, biocon has provided high quality medicines and treatments to millions of patients across the globe. Find the latest press releases and official documents published by biocon limited on marketscreener. Biocon limited has informed the exchange about investor presentation. investor presentation. press release. the exchange has received the disclosure under regulation 29 (2) of sebi. Access biocon's latest & archived press releases, intended information for business journalists, news & social media, analysts & investors.
Comments are closed.